Luis Augusto Aguirre

7PUBLICATIONS
18CO-AUTHORS
Infectious diseasesChemotherapyInnate immunityPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study.

Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Karla Montalbán-Hernández

|Oct 28, 2021
The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission.

José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós

|Aug 07, 2021
Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients.

Karla Montalbán-Hernández, Ramón Cantero-Cid, Roberto Lozano-Rodríguez

|Jun 29, 2021
SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.

José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós

|Oct 05, 2018
PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?

Ramón Cantero-Cid, José Casas-Martin, Enrique Hernández-Jiménez

Pageof 2